Steven T Rosen

9PUBLICATIONS
44CO-AUTHORS
Chemical engineering designCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 28, 2026
Calcitriol-PKM2 axis drives transcriptional and metabolic reprogramming of ILCPs into intestinal dual-cytokine-producing ILC3s.

|Jan 01, 2026
International Cost-Effectiveness Analysis of Nivolumab Versus Brentuximab Vedotin for Patients With Advanced-Stage Classic Hodgkin's Lymphoma.

Youwen Zhu, Kun Liu, Steven T Rosen

|Feb 14, 2025
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphoma.

Christiane Querfeld, Joycelynne Palmer, Zhen Han

|May 29, 2023
P38 kinase in gastrointestinal cancers.

Thuy Phan, Xu Hannah Zhang, Steven Rosen

|Apr 17, 2023
METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL.

Yiming Wu, Meiling Jin, Mike Fernandez

|Mar 26, 2022
SUMOylation inhibition enhances multiple myeloma sensitivity to lenalidomide.

Li Du, Wei Liu, Flavia Pichiorri

Pageof 2

Frequent Collaborators

2 joint publications

Christiane Querfeld

2 joint publications

Raju Pillai

1 joint publications

Laleh G Melstrom

1 joint publications

Qingyang Liu